Short bowel syndrome (SBS) encompasses a spectrum of metabolic and physiological disturbances resulting from massive anatomical or functional loss of small bowel. The clinical course of an infant who has undergone extensive small bowel resection is characterised by an initial period of watery diarrhoea, which is exacerbated by enteral nutrition and gastric hypersecretion. This is gradually replaced by a phase of progressive intestinal adaptation which often continues for more than a year and during which incremental enteral feeding is possible. Initial management is aimed at promoting and maintaining growth in the expectation that subsequent adaptational changes in the residual bowel will, in most cases, eventually permit full enteral feeding to be established. Should there be insufficient residual small bowel, home parenteral feeding allows long term survival with a good quality of life. More recently small bowel transplantation has become a further option in management. Although intravenous nutrition has transformed the prognosis of patients with SBS, complications associated with this treatment represent an important cause of morbidity and mortality.
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Aetiology of short bowel
The commonest causes are necrotising enterocolitis, multiple intestinal atresias and midgut volvulus but gastroschisis and extensive intestinal aganglionosis account for some cases. Although Adaptation of the residual intestine Massive small bowel resection is followed by a process of adaptation12 involving cell hyperplasia and leading to increased mucosal surface area. There is, however, less potential for adaptation in the jejunum than in the ileum. Other changes include increases in bowel circumference, length and bowel wall thickness, villus height, crypt depth, cell proliferation, and rate of cell migration up the villus. These adaptive processes begin immediately after loss of bowel, continue for some years, and are accompanied by adaptive changes in the stomach, pancreas, and colon.
Luminal nutrition is essential for the full development of adaptational changes and should begin as early as possible. Other trophic influences include pancreaticobiliary secretions and gut hormones such as enteroglucagon, gastrin, epidermal growth factor, and insulinlike growth factor.
Nutritional management
Good nutritional management is the key factor in achieving an optimal outcome in SBS. The goals of nutritional support should be to maintain normal growth, promote adaptation, and avoid complications. This is best done in a regional unit with a multidisciplinary nutri- Initial nasogastric flow rates are set at 1 ml/hour, and slowly increased over weeks or months as parenteral feed is reduced. The speed with which enteral nutrition can be increased depends upon the nature and length of the residual bowel. The ileal mucosa is more able to absorb solutes against a concentration gradient than jejunal mucosa. Loss of ileum is therefore likely to result in major fluid and electrolyte losses. The colon is important for energy salvage since unabsorbed carbohydrate is fermented by bacteria to produce short chain fatty acids. These are not only used by the mucosa as a major energy source but also have a trophic effect. Increasing the carbohydrate rather than the fat content of enteral feed may improve energy balance in patients with colon in continuity with small bowel. '9 Although enteral feed is better absorbed if given as a continuous infusion rather than by bolus, it is important to introduce some oral feeding as early as possible in order to avoid poor feeding and delayed speech development later on. The advice of a speech therapist should be sought at an early stage. Insertion of a percutaneous gastrostomy may be valuable in the older infant who is dependent upon nasogastric tube feeding.
As an alternative to a defined formula, a modular feed based on comminuted chicken (Chix, Cow and Gate) has the advantage of flexibility such that carbohydrate and fat content can be manipulated to suit individual requirements. For example, a combination of glucose polymer and sucrose may be better tolerated by an infant who has had necrotising enterocolitis with widespread mucosal damage. When there is fat maldigestion partial substitution of medium chain triglycerides for long chain triglycerides may be better tolerated, although feed osmolality will increase. Fat tolerance can be simply monitored using the steatocrit test20 in a way analogous to monitoring of carbohydrate intolerance by the presence of reducing substances in the stool. Outcome The development of parenteral nutrition and its continuing refinement has revolutionised the treatment of SBS. Nevertheless, progressive liver dysfunction and parenteral nutrition associated sepsis remain the leading causes of death in patients with SBS. The outcome of SBS is determined by many factors which include length and type of remaining small bowel, the presence of an ileocaecal valve and colon, and whether the remaining gut is healthy. Recent reviews of experience with neonatal SBS in single centres show survival rates of over 80% and a progressive reduction in morbidity over the last decade.'6 37 38 Successful weaning from parenteral nutrition has recently been described in an infant left with only 7 cm of jejunum anastomosed to ascending colon.39 However, in the absence of an ileocaecal valve, at least 10-20 cm of small bowel are usually required to achieve satisfactory long term enteral nutrition in infants. As small bowel length more than doubles in the fetus during the last trimester of pregnancy, gestational age may be a factor in subsequent adaptation.
